Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March
March 02 2021 - 8:00AM
Business Wire
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical
company focused on the discovery, development and commercialization
of innovative therapies for diseases of the eye, today announced
that management will participate in the following virtual
healthcare investor conferences in March.
H.C. Wainwright Global Life Sciences Conference Date:
March 9-10, 2021 Pre-recorded presentation will be made available
beginning Tuesday, March 9, 2021 at 7:00 am ET
Oppenheimer 31st Annual Healthcare Conference Date:
Tuesday, March 16, 2021 Fireside Chat at 3:50 pm ET
To access the webcasts and subsequent archived recording of each
presentation, please visit “Events” in the “Investors” section of
the Kala website at http://kalarx.com
About Kala Pharmaceuticals, Inc. Kala is a
biopharmaceutical company focused on the discovery, development,
and commercialization of innovative therapies for diseases of the
eye. Kala has applied its AMPPLIFY® mucus-penetrating particle
(MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS™
(loteprednol etabonate ophthalmic suspension) 0.25% for the
short-term (up to two weeks) treatment of signs and symptoms of dry
eye disease and INVELTYS® (loteprednol etabonate ophthalmic
suspension) 1% for the treatment of post-operative inflammation and
pain following ocular surgery. The Company also has a pipeline of
preclinical development programs targeted to address unmet medical
needs, including both front and back of the eye diseases. For more
information on Kala, please visit www.kalarx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210302005111/en/
Loraine Spreen loraine.spreen@kalarx.com 857-277-4842
Hannah Deresiewicz hannah.deresiewicz@sternir.com
212-362-1200
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Mar 2024 to Apr 2024
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Apr 2023 to Apr 2024